Global Treatment for Neglected Tropical Disease Market 2017-2027

LONDON, October 2, 2017 /PRNewswire/ --

Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease

The Global Treatment for Neglected Tropical Disease market is expected to grow at a CAGR of 7.3% in the second half of the forecast period. The Global Treatment for Neglected Tropical Disease market reached $1.5bn in 2016, dominated by the treatments for malaria which held 30% share of the market.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 157-page report you will receive 71 tables and 80 figures- all unavailable elsewhere.

The 157-page report provides clear detailed insight into the Global Treatment for Neglected Tropical Disease market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Global Treatment for Neglected Tropical Disease market forecasts from 2017-2027

• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market  by disease type:
- Malaria treatments
- Dengue treatments
- Leishmaniasis
- Schistosomiasis
- Lymphatic Filariasis
- Chagas Disease
- Others

For each disease type, the report provides a SWOT analysis, a list of selected drugs and revenue forecasts from 2017-2027 of the leading drugs.

• This report provides revenue forecast for these leading drugs:
- Coartem (Novartis)
- Clindamycin (Pfizer)
- Dengvaxia (Sanofi)
- AmBisome (Gilead Sciences)
- Impavido (Knight Therapeutics)
- ALBENZA (Amedra Pharmaceuticals LLC)

• This report also breaks down the revenue forecast for the Global Treatment for Neglected Tropical Disease market by regional and national market:
- North America: US and Canada
- Europe: Germany, the UK, France, Spain, Italy, Rest of Europe
- Asia-Pacific: Japan, China, India, Rest of Asia
- Latin America: Brazil, Mexico, Rest of Latin America
- Middle East & Africa: Saudi Arabia, South of Africa, Rest of Middle East & Africa

Each regional market is further broken down by disease type.

• This report provides company overview, financial information, product portfolio and recent developments for the leading companies in the neglected tropical disease market:
- Pfizer, Inc.
- Bayer
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis International AG
- Takeda Pharmaceutical Company Ltd
- Sanofi S.A.
- Eisai Co., Ltd

Buy our report today Global Treatment for Neglected Tropical Disease Market 2017-2027: Malaria, Dengue, Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease.

To request a report overview of this report please email Sara Peerun at [email protected] or call Tel: +44-(0)-20-7336-6100

Or click on https://www.visiongain.com/Report/2002/Global-Treatment-for-Neglected-Tropical-Disease-Market-2017-2027

List of Companies Mentioned in The Report 

Actiza Pharmaceutical

Amedra Pharmaceuticals LLC

APP Pharmaceuticals LLC

Asian Development Bank

Bayer

Bristol-Myers Squibb

Comic Relief

Cyper Pharma

Eisai Co., Ltd

F. Hoffmann-La Roche AG

Gilead Sciences

GlaxoSmithKline plc

Janssen

Johnson & Johnson

Kadmon Pharmaceuticals LLC

Knight Therapeutics

Merck

Nicholas Piramal India Ltd.

Novartis International AG

Pfizer, Inc.

Sanofi S.A.

Takeda Pharmaceutical Company Ltd

To see a report overview please email Sara Peerun on [email protected]

SOURCE Visiongain Ltd